Lallemand Health Solutions is launching the first and unique organic version of probiotic yeast Saccharomyces boulardii to mark the hundredth anniversary of…
Lallemand is joining forces by getting involved in the steering committee of the Grand Défi Ferments du Futur[1], a highly strategic program…
Sylvie Binda, vice-president research and development at Lallemand Health Solutions has been elected as a new member of the board of directors…
Vincent Thomas, Ph.D., is joining Lallemand Health Solutions as R&D Innovation Director. Mr. Thomas will start his new position on December 5…
Lallemand Health Solutions team will be at the Food ingredients (Fi) Europe, co-hosted with Health ingredients (Hi) Europe, from December 6 to…
Lallemand Health Solutions will be presenting its nutricosmetics innovations at Cosmetic 360®, the international innovation fair for cosmetic and perfume industry held…
Lallemand Health Solutions is joining forces with the French Gut Project, which aims to collect 100,000 French intestinal metagenomes for analysis, and…
For the first time a health authority recognizes that probiotics, particularly Lallemand Health Solutions strains Bifidobacteria infantis Rosell®-33, and Bifidobacteria bifidum Rosell®-71,…
Lallemand Health Solutions inaugurated its ultra-modern probiotic bacteria production plant, Harmonium II, with elected officials from the Mirabel region, Ms. Sylvie D’Amours,…
The Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a…
